Localization of TGF-β type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs

Molecular Vision

Volumn 14, Issue , 2008, Pages 136-141

  Meyer ter Vehn, Tobias ^a   Grehn, Franz ^a   Schlunck, Günther ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIBODY; CD31 ANTIGEN; ED A FIBRONECTIN; FIBRONECTIN; MEMBRANE PROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SIALOGLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONJUNCTIVA DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FILTERING BLEB SCAR; FILTERING OPERATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RISK FACTOR; SCAR FORMATION; WOUND HEALING;

ACTINS; ADOLESCENT; ADULT; AGED; ALTERNATIVE SPLICING; ANTIGENS, CD31; BIOLOGICAL MARKERS; BLISTER; CELL COUNT; CHILD; CONJUNCTIVA; ENDOTHELIUM; FEMALE; FIBROBLASTS; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 38749152479     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-63.
2. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331:1286-92.
3. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthahnol Vis Sci 1993; 34:477-87.
4. Pasquale LR, Dottman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-beta- 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993; 34:23-30.
5. Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M, Hayashi H, Glaser BM. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989; 83:1661-6.
6. Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor-beta. Invest Oplithalmol Vis Sci 1995; 36:1709-13.
7. Cordeiro MF. Role of transforming growth factor beta in conjunctival scarring. Clin Sci (Lond) 2003; 104:181-7.
8. Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT. Evalluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Opthalmol Vis Sci 2003; 44:3394-401.
9. CAT-152 0102 Trabeculectomy Study Group. Khaw P, Grehn F, Hollo G, Overton B, Wilson R, Vogel R, Smith Z. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 2007; 114:1822-30.
10. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts All, Sporn MB. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84:5788-92.
11. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998; 142:873-81.
12. Saika S, Yamanaka O, Baba Y, Kawashima Y, Shirai K, Miyamoto T, Okada Y, Ohnishi Y. Ooshima A. Accumulation of latent transforming growth factor-beta binding protein-1 and TGF beta 1 in extracellular matrix of filtering bleb and of cultured human subconjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmo~ 2001; 239:234-41.
13. Esson DW, Popp MP, Liu L, Schultz, GS, Sherwood MB. Microarray analysis of the failure... of filtering blebs in a rat model of glaucoma filtering surgery. Invest Ophthalmol Vis Sci 2004; 45:4450-62.
14. Schmid P, Itin P, Cherry G, Bi C, Cox DA. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 1998; 152:485-93.
15. Ten Dijke P, Goumans MJ, Itoh F, Iteh. S.Regulation of cell proliferation by Smad proteiks. J Cell Physiol 2002; 191:1-16.
16. Goumans MJ, Lebra F, Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 2003; 13:301-7.
17. Lebrin F, Deckers M, Bertolino P, Ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc Res 2005; 65:599-608.
18. Picht G, Grehn F. Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 1998; 9:2-8.
19. Bloom BB, Humphries DE, Kuang PP, Fine A, Goldstein RH. Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim Biophys Acta 1996; 1312:243-8.
20. McWhirter A, Colosetti P, Rubin K, Miyazono K, Black C. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. Lab Invest 1994; 71:885-94.
21. Gold LI, Sung JJ, Siebert JW, Longaker MT, Type I. RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am J Pathol 1997; 150:209-22.
22. Garner WL, Karmiol S, Rodriguez JL, Smith DJ Jr, Phan SH. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol 1993; 101:875-9.
23. Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttimann M, Grehn F, Schlunck G, Knaus P. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 2006; 47:1500-9.
24. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988; 263:7741-6.
25. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science 2005; 310:1139-43.
26. Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 2003; 162:149-60.